Print

Kythera Biopharmaceuticals (KYTH) Appoints F. Michael Ball to Board of Directors  
9/20/2013 10:00:44 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CALABASAS, Calif., Sept. 19, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it has named F. Michael (Mike) Ball, Chief Executive Officer (CEO) of Hospira, Inc. (NYSE:HSP) to its Board of Directors.

Help employers find you! Check out all the jobs and post your resume.

//-->